Cases
Search
Statistics
Estimate
SEARCH
Show Filters
Decision Date
2020
(2)
2019
(1)
2018
(2)
Decision
Transfer
(5)
Complainant
The Dow Chemical Company
(1)
Samuel Hubbard Shoe Company LLC
(1)
Facebook, Inc.
(1)
Autodesk, Inc.
(1)
American Society of Hematology, Inc.
(1)
Respondent
陶黎明(liming)
(1)
Zhao Hao
(1)
Tongzhu Gao, Dow Chemicalgroupholdingslldngongsi
(1)
Tongzhu Gao, Dow Chemicalgroupholdingsllc
(1)
Nexperian Holding Limited / wu xi si jie ruan jian you xian gong si
(1)
Gao Tongzhu, Dow Chemicalgroupholdingsllc
(1)
Domain Administrator, Fundacion Privacy Services LTD
(1)
Panelist
Matthew Kennedy
(5)
Complainant Country
United States
(5)
Complainant Representative
SafeNames Ltd.
(1)
Nelson Mullins Riley & Scarborough, L.L.P.
(1)
Lovells
(1)
GigaLaw
(1)
Donahue Fitzgerald LLP
(1)
Respondent Country
China
(3)
United States
(1)
Panama
(1)
Respondent Reply
Yes
(2)
No
(3)
RDNH Status
No
(5)
Case Language
English
(5)
Case Particular
D
(5)
Number Of Domains
1
(3)
6
(1)
8
(1)
Domain Extension
net
(5)
com
(2)
Domain Extension Type
gTLD
(5)
Domain Length
6
(1)
7
(1)
8
(1)
9
(1)
11
(1)
12
(2)
13
(1)
14
(1)
16
(1)
Includes Hyphen
Yes
(1)
No
(5)
Includes Number
Yes
(1)
No
(5)
Includes Letter
Yes
(5)
Domain Registrar
Alibaba Cloud Computing Ltd. d/b/a HiChina (www.net.cn)
(2)
Shanghai Meicheng Technology Information Development Co., Ltd.
(1)
Media Elite Holdings Limited
(1)
Key-Systems GmbH
(1)
5
cases found.
Complainant Country: United States
Domain Extension: net
Domain Extension Type: gTLD
Panelist: Matthew Kennedy
Reset Search
bloodjournal.net
Transfer
WIPO D2020-1887
(Decision Date: Aug. 27, 2020)
facebookwallet.net
Transfer
WIPO D2020-1347
(Decision Date: July 21, 2020)
autocad2031.com, diyrevit.com, revitcn.net and 5 others...
Transfer
WIPO D2019-0771
(Decision Date: July 1, 2019)
dowchemicalgroup.com, dowchemicalgroup.net, dowchenicalgroup.com and 3 others...
Transfer
WIPO D2018-2038
(Decision Date: Oct. 30, 2018)
samuelhubbard.net
Transfer
WIPO D2018-0052
(Decision Date: March 5, 2018)
Stay updated! Get new cases and decisions by daily email.
leave this field blank to prove your humanity
Subscribe
Scroll